IMARC Group, a leading market research company, has recently releases report titled “Autoimmune Disease Diagnosis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” The study provides a detailed analysis of the industry, including the global autoimmune disease diagnosis market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights
Table of Contents
How big is the autoimmune disease diagnosis market?
The global autoimmune disease diagnosis market size reached US$ 3.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.8% during 2023-2028
What is an autoimmune disease diagnosis?
An autoimmune disorder is a medical condition caused by an abnormal immune response to a normally functioning part of the body. It happens when the immune system is unable to recognize healthy tissues and potentially harmful antigens. As a result, it attacks them with autoantibodies, which destroy the tissues, functioning cells, and organs of the body. These conditions can be diagnosed through a combination of physical examination, C-reactive protein (CRP), tissue biopsy, antinuclear antibody test (ANA), and X-rays to determine the severity and nature of the condition. Consequently, autoimmune disease diagnosis solutions are widely adopted in clinical laboratories and hospitals across the globe.
Request for a sample copy of this report: https://www.imarcgroup.com/autoimmune-disease-diagnosis-market/requestsample
What are the growth prospects and trends in the autoimmune disease diagnosis industry?
The market is primarily driven by the increasing occurrences of chronic ailments such as psoriasis, rheumatoid arthritis, type I diabetes, multiple sclerosis, and inflammatory bowel disease. In addition, the escalating demand for accurate and efficient diagnostic solutions is contributing to market growth. Moreover, the adoption of advanced technologies to perform multiple tests with quick and precise results, improved diagnosis, and higher sensitivity represents another major growth-inducing factor. Besides this, numerous governments, non-government organizations (NGOs), and research and diagnostics institutes are taking the initiative to raise awareness regarding the diagnosis and treatment of autoimmune disorders, which is accelerating the product adoption rate. Furthermore, the market is propelled by the development of novel therapeutics, such as the AMP RA/SLE program launched by accelerating medicines partnership (AMP) that aims at identifying relevant drug targets for the treatment of autoimmune diseases. Apart from this, increasing healthcare expenditure and investment in research and diagnostic institutes for developing better diagnostic methods and therapies are creating a positive market outlook.
What is included in market segmentation?
The report has segmented the market into the following categories:
Product Type Insights:
- Consumables and Assay Kits
- Instruments
Disease Type Insights:
- Systemic Autoimmune Disease
- Rheumatoid Arthritis
- Psoriasis
- Systemic Lupus Erythematosus (SLE)
- Multiple Sclerosis
- Others
- Localized Autoimmune Disease
- Inflammatory Bowel Disease
- Type 1 Diabetes
- Thyroid
- Others
Test Type Insights:
- Routine Laboratory Tests
- Inflammatory Markers
- Autoantibodies and Immunologic Tests
- Others
End-User Insights:
- Clinical Laboratories
- Hospitals
- Others
Breakup by Region:
- North America (U.S. Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
- Latin America (Brazil, Mexico)
- Middle East Africa
Who are the key players operating in the industry?
The report covers the major market players including:
- Abbott Laboratories
- GROUP
- Danaher Corp.
- bioMérieux SA
- Bio-Rad Laboratories
- PerkinElmer Inc.
- Hemagen Diagnostics, Inc.
- Inova Diagnostics, Inc.
- Myriad Genetics, Inc.
- Quest Diagnostics Incorporated
- Siemens Healthineers AG
- SQI Diagnostics
- Thermo Fisher Scientific Inc.
- Trinity Biotech plc.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
